Patents by Inventor Gerardo Garcia

Gerardo Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10833571
    Abstract: A press-fit mounting peg (2) for retaining a component such as a stepped-motor on a circuit board (21). The mounting peg (2) is securable in a mounted position by a first axial displacement of a locking pin (17) along a pin channel (16) of the press-fit mounting peg (2) in a first axial direction along a longitudinal axis of the press-fit mounting peg (2) from a first axial position to a second axial position. The pin channel (16) comprises at least one pin displacement stop (13, 20) for stopping a second axial displacement of the locking pin (17) out of the second axial position.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: November 10, 2020
    Assignee: JUKEN SWISS TECHNOLOGY AG
    Inventors: Rodolfo Esposito, Gerardo Garcia, Daniel Maeder
  • Patent number: 10823687
    Abstract: A system and method for detecting, measuring, and analyzing for metallic impurities in pharmaceutical drugs and compounds utilizes an x-ray fluorescence system. The system and method may be co-located with a pharmaceutical manufacturing process for in-line continuous monitoring of metal impurities. The pharmaceutical products may be in a form selected from a powder, slurry, pill, tablet, and gel.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: November 3, 2020
    Assignee: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, Jr.
  • Publication number: 20200290088
    Abstract: A system classifies materials utilizing a vision system that implements a machine learning system, such as a neural network, in order to identify or classify each of the materials as either a monetary coin or not a monetary coin, which may then be sorted into separate groups based on such an identification or classification. Such a system can sort monetary coins from other forms of scrap, which may have been produced from a shredding of end of life vehicles.
    Type: Application
    Filed: April 19, 2020
    Publication date: September 17, 2020
    Applicant: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, JR., Ronnie Kip Lowe
  • Patent number: 10722922
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification determining that the materials are composed of either wrought aluminum or cast aluminum.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: July 28, 2020
    Assignee: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, Jr., Isha Kamleshbhai Maun
  • Patent number: 10710119
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification. The material sorting system may include an x-ray fluorescence system to perform a classification of the materials in combination with the vision system, whereby the classification efforts of the vision system and x-ray fluorescence system are combined in order to classify and sort the materials.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: July 14, 2020
    Assignee: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, Jr., Kanishka Tyagi
  • Publication number: 20200197421
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Application
    Filed: March 3, 2020
    Publication date: June 25, 2020
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Publication number: 20200197419
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Application
    Filed: March 3, 2020
    Publication date: June 25, 2020
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Publication number: 20200197420
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Application
    Filed: March 3, 2020
    Publication date: June 25, 2020
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Dept. of Health and Human Service
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Patent number: 10625304
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification determining that the materials have a specified geometric shape. Such a system can sort monetary coins or other valuable metals from other forms of scrap.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: April 21, 2020
    Assignee: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, Jr., Ronnie Kip Lowe
  • Publication number: 20200101072
    Abstract: Disclosed is the use of a nucleoside reverse transcriptase inhibitor, a nucleotide reverse transcriptase inhibitor, and an integrase inhibitor after exposure to a potential human immunodeficiency virus (HIV) infection to inhibit or prevent an HIV infection. In some embodiments, a pharmacologically effective amount of emtricitabine (FTC), a pharmacologically effective amount of tenofovir alafenamide (TAF) or tenofovir disproxil fumarate (TDF), a pharmacologically effective amount of the integrase inhibitor elvitegravir (EVG), and optionally cobistat (COBI) are used to inhibit or prevent an HIV infection, wherein these agents are administered only after a potential exposure to HIV. In specific non-limiting examples, only one or two doses of the anti-retroviral viral agents are administered to a subject after the potential exposure to HIV.
    Type: Application
    Filed: March 19, 2018
    Publication date: April 2, 2020
    Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC
    Inventors: Jose Gerardo Garcia Lerma, Ivana Mabel Massud, Walid M. Heneine
  • Patent number: 10436721
    Abstract: A linear x-ray tube having one or more x-ray sources is configured for insertion into the soil in proximity to a root system of a plant for emission of an x-ray beam detected by a linear array of one or more x-ray detectors. The linear x-ray tube and detector array may be inserted into rhizotrons previously inserted into the soil. Various combinations of multiple x-ray tubes and/or detector arrays may be utilized to customize the x-ray imaging of the root system.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: October 8, 2019
    Assignee: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia
  • Publication number: 20190269708
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Application
    Filed: May 15, 2019
    Publication date: September 5, 2019
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Publication number: 20190247891
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification determining that the materials are composed of either wrought aluminum or cast aluminum.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 15, 2019
    Applicant: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, JR., Isha Kamleshbhai Maun
  • Publication number: 20190210067
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification determining that the materials have a specified geometric shape. Such a system can sort monetary coins or other valuable metals from other forms of scrap.
    Type: Application
    Filed: March 19, 2019
    Publication date: July 11, 2019
    Applicant: UHV Technologies, Inc.
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, JR., Ronnie Kip Lowe
  • Patent number: 10335423
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: July 2, 2019
    Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Patent number: 10207296
    Abstract: A material sorting system sorts materials, such as scrap pieces composed of unknown metal alloys, as a function of their detected x-ray fluorescence. The x-ray fluorescence may be converted into an elemental composition signature that is then compared to an elemental composition signature of a reference material in order to identify and/or classify each of the materials, which are then sorted into separate groups based on such an identification/classification. The material sorting system may include an in-line x-ray tube having a plurality of separate x-ray sources, each of which can irradiate a separate stream of materials to be sorted.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: February 19, 2019
    Assignee: UHV Technologies, Inc.
    Inventors: Manuel Gerardo Garcia, Nalin Kumar, Subodh Das
  • Publication number: 20180243800
    Abstract: A material sorting system sorts materials utilizing a vision system that implements a machine learning system in order to identify or classify each of the materials, which are then sorted into separate groups based on such an identification or classification. The material sorting system may include an x-ray fluorescence system to perform a classification of the materials in combination with the vision system, whereby the classification efforts of the vision system and x-ray fluorescence system are combined in order to classify and sort the materials.
    Type: Application
    Filed: April 26, 2018
    Publication date: August 30, 2018
    Inventors: Nalin Kumar, Manuel Gerardo Garcia, JR., Kanishka Tyagi
  • Publication number: 20180193366
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Application
    Filed: March 6, 2018
    Publication date: July 12, 2018
    Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Patent number: 9937191
    Abstract: A process is provided for protecting a primate host from a self-replicating infection by an immunodeficiency retrovirus. Protection is achieved by administering to the primate host a combination of a pharmaceutically effective amount of a nucleoside reverse transcriptase inhibitor and a pharmaceutically effective amount of a nucleotide reverse transcriptase inhibitor prior to exposure to the immunodeficiency retrovirus. The administration is effective if provided in a single dose within 24 hours of the exposure. A regime of regular daily doses is also effective in providing protection against an immunodeficiency retrovirus becoming self-replicating after infecting a primate host.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: April 10, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Walid Heneine, Thomas M. Folks, Robert Janssen, Ronald A. Otten, Jose Gerardo Garcia Lerma
  • Patent number: 9880604
    Abstract: In a device, one or more low energy sensors are used to determine a mobility state of the device. Based on both the mobility state of the device and one or more places of interest for the device, a determination is made as to when to use a high energy sensor to determine a location of the device. One of the one or more places of interest for the device within which the device is located at any particular time can be determined based on the mobility state of the device and/or the location of the device as determined by the high energy sensor.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: January 30, 2018
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Aman Kansal, Brian D. Cross, Gerardo Garcia